Published in
Elsevier, The Lancet Oncology, 4(12), p. 361-368, 2011
DOI: 10.1016/s1470-2045(11)70062-6
Links
- ORCID
- Elsevier
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study
Journal article published in 2011 by
Stephen M. Ansell,
Hui Tang,
Paul J. Kurtin,
Patricia A. Koenig,
David J. Inwards,
Keith Shah,
Steven C. Ziesmer,
Andrew L. Feldman 
,
Radha Rao,
Mamta Gupta,
Charles Erlichman,
Thomas E. Witzig
,
Radha Rao,
Mamta Gupta,
Charles Erlichman,
Thomas E. Witzig
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 